Becton, Dickinson and Co. | BDX - Cost Of Sales


Becton, Dickinson and Co. reported $2.67B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Agilent USD 845M 7M Mar/2026
Align Technology USD 298.76M 4.74M Jun/2026
AngioDynamics USD 37.29M 786K Sep/2025
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Bio-Rad Laboratories USD 305.2M 22.5M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Cooper Companies USD 393.8M 17M Mar/2026
Danaher USD 2.65B 294M Jun/2026
Dentsply International USD 405M 48M Jun/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
J&J USD 8B 67M Jun/2026
Medtronic USD 3.8B 195M Mar/2026
Solventum Corp USD 923M 12M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Terumo JPY 133.27B 18.03B Jun/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026